Is it possible to sustain adequate immunosuppressive efficacy minimizing the nephrotoxicity with a regimen including low doses of calcineurin inhibitors or sirolimus? S. Jiménez, J. Zamora, A. Muriel, J. Pascual

Conversion to sirolimus J. C. Ruiz, A. Alonso, M. Arias, J. M. Campistol, M. González Molina, J. M. González Posada,J. M. Grinyo, J. M. Morales, F. Oppenheimer, A. Sánchez Fr

SIROLIMUS - MONOGRAPH INDEX M. Arias, J. M. Campistol, J. M. Grinyo, J. M. Morales, F. Oppenheimer